Literature DB >> 35288874

Phosphate Toxicity and Epithelial to Mesenchymal Transition.

Eric Lewis1, Faith Seltun1, Mohammed S Razzaque2, Ping He3.   

Abstract

The underlying role of inadequate or excess intake of phosphate is evident in disease states, including metabolic, skeletal, cardiac, kidney and various cancers. Elevated phosphate levels can induce epithelial to mesenchymal transition (EMT) and cell death. EMT and associated lethal, metastatic or fibrinogenic responses are known to be underlying disease processes in fibrotic diseases and various solid tumors. Studies have shown EMT is regulated by induction of different signaling pathways, including TGF-β, RTK, SRC, Wnt and Notch signal transduction. However, cross-talk amongst these signaling pathways is less understood. We have shown that elevated phosphate levels enhanced EMT partially through activating ERK1/2 pathway, resulting in massive cell death. We thus proposed excess phosphate-mediated lethal EMT as one of the underlying mechanisms of phosphate-induced cytotoxicity, which could explain high phosphate-associated renal fibrosis and cancer metastasis in preclinical and clinical studies. This chapter provides the overview of EMT with the highlights of its regulation by various signaling pathways induced by phosphate toxicity. We further put lately reported lethal EMT in the context of phosphate toxicity with the intent to explain it to excessive phosphate-associated pathologies.
© 2022. Springer Nature Switzerland AG.

Entities:  

Keywords:  Apoptosis; Cytotoxicity; EMT; Phosphate

Mesh:

Substances:

Year:  2022        PMID: 35288874     DOI: 10.1007/978-3-030-91623-7_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  82 in total

Review 1.  Phosphate toxicity and tumorigenesis.

Authors:  Ronald B Brown; Mohammed S Razzaque
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-04-21       Impact factor: 10.680

2.  Elevated inorganic phosphate stimulates Akt-ERK1/2-Mnk1 signaling in human lung cells.

Authors:  Seung-Hee Chang; Kyeong Nam Yu; Yeon-Sook Lee; Gil-Hwan An; George R Beck; Nancy H Colburn; Kee-Ho Lee; Myung-Haing Cho
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-08       Impact factor: 6.914

3.  Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration.

Authors:  A V Bakin; A K Tomlinson; N A Bhowmick; H L Moses; C L Arteaga
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

4.  Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium.

Authors:  Nuzhat Ahmed; Sarah Maines-Bandiera; Michael A Quinn; Waldemar G Unger; Shoukat Dedhar; Nelly Auersperg
Journal:  Am J Physiol Cell Physiol       Date:  2006-01-04       Impact factor: 4.249

Review 5.  Inorganic phosphate as a signaling molecule in osteoblast differentiation.

Authors:  George R Beck
Journal:  J Cell Biochem       Date:  2003-10-01       Impact factor: 4.429

6.  An integrated understanding of the physiological response to elevated extracellular phosphate.

Authors:  Corinne E Camalier; Ming Yi; Li-Rong Yu; Brian L Hood; Kelly A Conrads; Young Jae Lee; Yiming Lin; Laura M Garneys; Gary F Bouloux; Matthew R Young; Timothy D Veenstra; Robert M Stephens; Nancy H Colburn; Thomas P Conrads; George R Beck
Journal:  J Cell Physiol       Date:  2013-07       Impact factor: 6.384

7.  ERK1/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition.

Authors:  Janine M Buonato; Matthew J Lazzara
Journal:  Cancer Res       Date:  2013-10-09       Impact factor: 12.701

8.  Erk5 controls Slug expression and keratinocyte activation during wound healing.

Authors:  Valerie Arnoux; Mayssaa Nassour; Annie L'Helgoualc'h; Robert A Hipskind; Pierre Savagner
Journal:  Mol Biol Cell       Date:  2008-08-20       Impact factor: 4.138

9.  Phosphorus is associated with coronary artery disease in patients with preserved renal function.

Authors:  Ana Ludimila Cancela; Raul Dias Santos; Silvia Maria Titan; Patrícia Taschner Goldenstein; Carlos Eduardo Rochitte; Pedro Alves Lemos; Luciene Machado dos Reis; Fabiana Giorgetti Graciolli; Vanda Jorgetti; Rosa Maria Moysés
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

10.  Interstitial Inorganic Phosphate as a Tumor Microenvironment Marker for Tumor Progression.

Authors:  Andrey A Bobko; Timothy D Eubank; Benoit Driesschaert; Ilirian Dhimitruka; Jason Evans; Rahman Mohammad; Elena E Tchekneva; Mikhail M Dikov; Valery V Khramtsov
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

View more
  1 in total

1.  Phosphate Burden and Organ Dysfunction.

Authors:  Nikolay Mironov; Azeddine Atfi; Mohammed S Razzaque
Journal:  Front Aging       Date:  2022-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.